Find Flupentixol Dihydrochloride manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 51529-01-2, Flupenthixol dihydrochloride, Emergil, Cis-(z)-flupenthixol dihydrochloride, 2413-38-9, Flupentixol hcl
Molecular Formula
C23H27Cl2F3N2OS
Molecular Weight
507.4  g/mol
InChI Key
IOVDQEIIMOZNNA-MHKBYHAFSA-N
FDA UNII
96L0Z069N1

Flupentixol Dihydrochloride
A thioxanthene neuroleptic that, unlike CHLORPROMAZINE, is claimed to have CNS-activating properties. It is used in the treatment of psychoses although not in excited or manic patients. (From Martindale, The Extra Pharmacopoeia, 30th ed, p595)
1 2D Structure

Flupentixol Dihydrochloride

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[(3Z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol;dihydrochloride
2.1.2 InChI
InChI=1S/C23H25F3N2OS.2ClH/c24-23(25,26)17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)30-22)5-3-9-27-10-12-28(13-11-27)14-15-29;;/h1-2,4-8,16,29H,3,9-15H2;2*1H/b18-5-;;
2.1.3 InChI Key
IOVDQEIIMOZNNA-MHKBYHAFSA-N
2.1.4 Canonical SMILES
C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl
2.1.5 Isomeric SMILES
C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl
2.2 Other Identifiers
2.2.1 UNII
96L0Z069N1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Alpha-flupenthixol

2. Cis-flupenthixol

3. Emergil

4. Fluanxol

5. Flupenthixol

6. Flupentixol

2.3.2 Depositor-Supplied Synonyms

1. 51529-01-2

2. Flupenthixol Dihydrochloride

3. Emergil

4. Cis-(z)-flupenthixol Dihydrochloride

5. 2413-38-9

6. Flupentixol Hcl

7. Cis-(z)-flupentixol Dihydrochloride

8. Fupentixol Dihydrochloride

9. (z)-flupenthixol Dihydrochloride

10. Flupenthixol 2hcl

11. (e/z)-flupentixol Dihydrochloride

12. Flupenthixol, Dihydrochloride

13. Fx 703

14. Flupentixol Dihydrochloride Cis-(z)

15. 96l0z069n1

16. Cis-(z)-flupentixol (dihydrochloride)

17. Flupentixol Hydrochloride

18. (z)-4-[3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Dihydrochloride

19. 2-[4-[(3z)-3-[2-(trifluoromethyl)thioxanthen-9-ylidene]propyl]piperazin-1-yl]ethanol;dihydrochloride

20. N 7009

21. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Dihydrochloride, (z)-

22. (z)-4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-1-piperazineethanol Dihydrochloride

23. Einecs 219-321-4

24. Nsc 170952

25. Unii-96l0z069n1

26. Prestwick_902

27. Cis-flupenthixol 2hcl

28. Unii-hat84mlq6z

29. Hat84mlq6z

30. 1-piperazineethanol, 4-(3-(2-trifluoromethylthioxanth-9-ylidene)propyl)-, Dihydrochloride

31. 4-(3-(2-(trifluoromethyl)thioxanthen-9-ylidene)propyl)-1-piperazineethanol Dihydrochloride

32. Cis-flupenthixol Hydrochloride

33. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Dihydrochloride

34. Cis-flupenthixol Dihydrochloride

35. (z)-flupentixol Dihydrochloride

36. Schembl1153162

37. Chembl1496351

38. Ex-a352

39. Chebi:180489

40. Flupentixol Dihydrochloride (jan)

41. Cis-(z)-flupentixoldihydrochloride

42. Dtxsid501017247

43. Hms1569c21

44. Cis(z)-flupentixol Dihydrochloride

45. 4-[3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Dihydrochloride

46. Cis-flupentixol Hydrochloride

47. Tox21_500528

48. Mfcd00069278

49. S3664

50. Akos025401529

51. Ac-2136

52. Ccg-221832

53. Lp00528

54. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)thioxanthen-9-ylidene)propyl)-, Dihydrochloride

55. Ncgc00093921-01

56. Ncgc00261213-01

57. .alpha.-flupenthixol Hydrochloride

58. 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)piperazine-1-ethanol Dihydrochloride

59. Bs-16961

60. Flupentixol Dihydrochloride, (z)-

61. Hy-15856

62. Thioxanthene, 9-(3-(4-(2-hydroxyethyl)piperazinyl)propylidene)-2-trifluoromethyl-, Dihydrochloride

63. B7578

64. Cs-0009393

65. Eu-0100528

66. F-114

67. D02236

68. 529f012

69. Sr-01000076232

70. J-015359

71. Sr-01000076232-1

72. Q27271910

73. Cis-(z)-flupenthixol Dihydrochloride, >=98% (hplc), Solid

74. (z)-2-(4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol Dihydrochloride

75. (z)-4-[3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazine-ethanol Dihydrochloride

76. 1-(2-hydroxyethyl)-4-{(3z)-3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl}piperazinediium Dichloride

77. 1-piperazineethanol, 4-((3z)-3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Dihydrochloride

78. 1-piperazineethanol, 4-(3-((3z)-2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, Hydrochloride (1:2)

79. 2-(4-{(3z)-3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethan-1-ol--hydrogen Chloride (1/2)

80. 2-(4-{(3z)-3-[2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethanol Dihydrochloride

81. 4-[3-[(3z)-2-(trifluoromethyl)-9h-thioxanthen-9-ylidene]propyl]-1-piperazineethanol Hydrochloride

2.4 Create Date
2005-10-11
3 Chemical and Physical Properties
Molecular Weight 507.4 g/mol
Molecular Formula C23H27Cl2F3N2OS
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass506.1173245 g/mol
Monoisotopic Mass506.1173245 g/mol
Topological Polar Surface Area52 Ų
Heavy Atom Count32
Formal Charge0
Complexity592
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antipsychotic Agents

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)


Dopamine Antagonists

Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)


Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty